Notes
2017 US dollars
Reference
Arbel R, et al. Usefulness of Empagliflozin Versus Liraglutide for Prevention of Cardiovascular Mortality. American Journal of Cardiology : 22 Jun 2018. Available from: URL: http://doi.org/10.1016/j.amjcard.2018.06.010
Rights and permissions
About this article
Cite this article
Empagliflozin cost saving for prevention of cardiovascular death. PharmacoEcon Outcomes News 810, 11 (2018). https://doi.org/10.1007/s40274-018-5202-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5202-x